Cost Barrier for Injectable Treatments Clinical data reveals that current regimens lack sustainability due to strong side effects: Gastrointestinal complications: Side Effects of Some Current Weight Loss Treatments (Forbes) Severe complications include acute pancreatitis, kidney injury, gallbladder injury, diabetic retinopathy, and gastroparesis
The dose itself might not change dramatically from the systemic protocol (e.g., 250-350mcg total per day), but the location of the administration is the key variable
Inventory is maintained to support ongoing laboratory supply requirements
This is one of those situations where two seemingly helpful agents can work at cross-purposes, creating a kind of biochemical dissonance that might completely undermine your objectives
However, some providers use gradual dose exposure to help patients adapt to GLP-1 medications while monitoring tolerance
25-vial cases offer the best value